EPMA Journal is a journal of predictive, preventive and personalized medicine (PPPM). The journal provides expert viewpoints and research on medical innovations and advanced healthcare using predictive diagnostics, targeted preventive measures and personalized patient treatments. The journal is indexed by PubMed, Embase and Scopus.
- The only journal in the field of predictive, preventive and personalized medicine (PPPM)
- High visibility for your research
- Official journal of the European Association for Predictive, Preventive & Personalised Medicine
- Olga Golubnitschaja
- Publishing model
- Hybrid. Open Access options available
- 4.901 (2019)
- Impact factor
- 21 days
- Submission to first decision
- 89 days
- Submission to acceptance
- 124,537 (2019)
Differences in cohort study data affect external validation of artificial intelligence models for predictive diagnostics of dementia - lessons for translation into clinical practice
Authors (first, second and last of 9)
A risk model of prenatal screening markers in first trimester for predicting hypertensive disorders of pregnancy
Authors (first, second and last of 8)
Comparative cerebrospinal fluid metabolites profiling in glioma patients to predict malignant transformation and leptomeningeal metastasis with a potential for preventive personalized medicine
Authors (first, second and last of 12)
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Societies around the world are facing the paradoxal epidemic development of prostate cancer (PCa) as a non-communicable disease. PCa is the most frequently diagnosed cancer for men in several countries such as the USA. Permanently improving diagnostics and treatments in the PCa management causes an impressive divergence between, on one hand, permanently increasing numbers of diagnosed PCa cases and, on the other hand, stable or even slightly decreasing mortality rates.
The article summarises knowledge accumulated in regard to the PCa-relevant non-modifiable and modifiable risk factors, highlights current deficits in PCa managements and presents innovative solutions in the context of predictive, preventive and personalised (3P) medicine.
SCImago Journal Rank (SJR) measures weighted citations received by the journal. Citation weighting depends on subject field and prestige (SJR) of the citing journal. The 2019 SJR for EPMA Journal is 1.263.
Source-Normalized Impact per Paper (SNIP) measures actual citations received relative to citations expected for the journal’s subject field. SNIP especially considers the frequency at which authors cite other papers in their reference lists, the speed at which citation impact matures and the extent to which the database used in the assessment covers the field’s literature. The 2019 SNIP for EPMA Journal is 1.469.
Dr. Golubnitschaja is the head of the world's first Predictive, Preventive and Personalised (3P) Medicine unit at the Department of Radiation Oncology, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Germany.
Societies, partners and affiliations
About this journal
- Electronic ISSN
- Print ISSN
- Abstracted and indexed in
- CAB Abstracts
- EBSCO Discovery Service
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- OCLC WorldCat Discovery Service
- ProQuest Central
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Science Citation Index Expanded (SciSearch)
- UGC-CARE List (India)